-
公开(公告)号:WO2016123253A1
公开(公告)日:2016-08-04
申请号:PCT/US2016/015195
申请日:2016-01-27
申请人: RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY , THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK , AUGERI, David, J. , BENCIVENGA, Anthony, F. , BLANDEN, Adam , CARPIZO, Darren, R. , GILLERAN, John, A. , KIMBALL, Spencer David , LOH, Stewart, N. , YU, Xin
发明人: AUGERI, David, J. , BENCIVENGA, Anthony, F. , BLANDEN, Adam , CARPIZO, Darren, R. , GILLERAN, John, A. , KIMBALL, Spencer David , LOH, Stewart, N. , YU, Xin
IPC分类号: C07D403/12 , C07D401/12 , C07D413/12 , C07D417/12 , C07D513/04 , A61K31/4427 , A61K31/4439 , A61P35/00
CPC分类号: A61K31/4439 , A61K31/4427 , C07D401/12 , C07D403/12 , C07D413/12 , C07D417/12 , C07D513/04
摘要: The invention provides compounds of formula (I): and salts thereof, wherein ring A, R 2 , HET, X, n, and R 3 have any of the meanings described in the specification, as well as compositions comprising such compounds and salts, and methods for treating cancer using such compounds and salts.
摘要翻译: 本发明提供式(I)化合物及其盐,其中环A,R 2,HET,X,n和R 3具有说明书中所述的任何含义,以及包含这些化合物和盐的组合物,以及方法 用于使用这些化合物和盐治疗癌症。
-
2.NOVEL MITOCHONDRIAL UNCOUPLERS FOR TREATMENT OF METABOLIC DISEASES AND CANCER 审中-公开
标题翻译: 用于治疗代谢性疾病和癌症的新型麻醉药公开(公告)号:WO2016081599A1
公开(公告)日:2016-05-26
申请号:PCT/US2015/061342
申请日:2015-11-18
发明人: JIN, Shengkan , AUGERI, David, J. , KIMBALL, David, S. , LIU, Peng , TAO, Hanlin , ZENG, Xiangang
IPC分类号: A61K31/16 , A61K31/44 , C07D277/62
CPC分类号: A61K31/166 , A61K31/155 , A61K31/428 , A61K31/437 , A61K31/47 , A61K31/4965 , A61K31/497 , A61K31/498 , A61K31/50 , A61K31/505 , A61K45/06 , C07D213/78 , C07D215/42 , C07D219/04 , C07D237/20 , C07D239/42 , C07D239/557 , C07D241/24 , C07D277/56 , C07D277/62 , C07D277/68 , A61K2300/00
摘要: 2-hydroxy-benzoic anilide compounds and derivatives, compositions thereof, and methods for treating metabolic diseases and cancer through uncoupling mitochondria.
摘要翻译: 2-羟基 - 苯甲酰苯胺化合物及其衍生物,其组合物,以及通过解偶联线粒体治疗代谢疾病和癌症的方法。
-